Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy

Podobne zapisy

• Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
  od: Docherty, Kieran F, i wsp.
  Wydane: (2020)
• Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial
  od: Kosiborod, Mikhail N., i wsp.
  Wydane: (2020)
• Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF
  od: Jhund, Pardeep S., i wsp.
  Wydane: (2021)
• A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF)
  od: McMurray, John J.V., i wsp.
  Wydane: (2019)
• Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
  od: Jackson, Alice M., i wsp.
  Wydane: (2020)